Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Henry Schein
NasdaqGS:HSIC Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Henry Schein
Popular
Undervalued
Overvalued
Henry Schein
WA
Analyst Price Target
Consensus Narrative from 13 Analysts
New Product Launches And Global Expansion Will Strengthen Market Presence
Key Takeaways Strategic focus on high-growth, high-margin products could significantly boost income and earnings as these areas scale. Global expansion and tech-driven e-commerce advancements position the firm for increased revenue and market share.
View narrative
US$76.33
FV
1.7% overvalued
intrinsic discount
4.61%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
21 days ago
author updated this narrative
Your Valuation for
HSIC
Henry Schein
Your Fair Value
US$
Current Price
US$77.63
2.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
15b
2015
2018
2021
2024
2025
2027
2030
Revenue US$15.2b
Earnings US$383.0m
Advanced
Set as Fair Value